Sentence examples for inappropriate point from inspiring English sources
It rang right at the most inappropriate point, with timing that was exquisite in its awfulness.In truly professional style, however, Sheila simply fixed me with a steely glare and carried on to the end, to great applause.
Have you ever been to a performance that was interrupted by a loud audience member or a mobile phone going off at the most inappropriate point in a play?
On the other hand, if the congestion is controlled at an inappropriate point and data packets are sent down to the buffer queue to occupy the channel only in the point of Semi-TCP's view, the QoS may become non-provisionable.
The Net Neutrality debate is getting so intense that rhetoric and tactics are escalating to an offensive and inappropriate point.
The equipoise principle is applied at an inappropriate point in time.
From the Bayesian perspective, frequentist confidence intervals are Bayesian intervals with inappropriate point priors at zero for bias parameters, e.g. misclassification probabilities [ 2, 7], and flat priors for the causal effect.
The ICO describes this cover-up as "inappropriate", pointing out that the hackers acted maliciously, as they sought to exploit a vulnerability to illegally gain access to data — so were not at all "legitimate bug bounty recipients".
"Some faith schools do have, we have evidence, inappropriate points systems in place that are not necessarily objective and they could relate to some sections of the community over others," he told MPs.
"They use an inappropriate starting point, 1989, which was a cyclical peak, thereby ignoring the deep recession that occurred afterwards," Mr. Kagann said.
Possibly, the median is an inappropriate cut point for this analysis, and groups of different sizes may be compared; other preanalysis cut points will be identified during the analysis of baseline data, as described below, reducing the detectable difference between density strata.
In particular, we discuss the poor translation of drug efficacy from preclinical animal models, inappropriate end point analysis, limited standards in phase I clinical trials, insufficient use of biomarker analysis and also patient stratification, all of which contributed to the failure to achieve approval of enzastaurin as an anticancer therapeutic.
